Pfizer's ex-chair and chief executive Ian Read and Frank D'Amelio – previously the drugmaker's finance chief – have issued a ...
Fresh record closes in the S&P and Dow might have been buoyed by a dovish Fed. But risks, like oil prices and increasing ...
GLP-1s are all the rage. So it should come as no surprise that shares of Mounjaro and Zepbound maker Eli Liily have soared ...